Opna Bio is a biotechnology company focused on discovering and developing small molecule inhibitors of a novel target, FMRP (fragile X mental retardation protein), for cancer immunotherapy.
Member count: 11-50
Total raised: $38M
Investors 1
| Date | Name | Website |
| 07.12.2022 | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.11.2022 | Series A | $38M | - | startuptic... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 22.11.2022 | Opna Bio L... | Opna Bio is a clinical-stage... | Financing | - | startuptic... |
| 22.11.2022 | Opna Bio R... | Opna Bio, an Epalinges, Switze... | Switzerlan... | - | finsmes.co... |
| 21.11.2022 | Opna Bio L... | Gideon Bollag, PhD, Named CEO ... | - | Business W... | venturebea... |
| - | Opna Bio | “Opna Bio” | - | - | fastfounde... |